Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton's Tyrosine Kinase (BTK) (Q92505400)
Jump to navigation
Jump to search
scientific article published on 29 March 2019
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton's Tyrosine Kinase (BTK) |
scientific article published on 29 March 2019 |
Statements
Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton's Tyrosine Kinase (BTK) (English)
Qingjie Liu
Myra Beaudoin Bertrand
Douglas G Batt
Ling Li
Mark A Pattoli
Stacey Skala
Lihong Cheng
Mary T Obermeier
Robin Moore
Zheng Yang
Rodney Vickery
Paul A Elzinga
Lorell Discenza
Celia D'Arienzo
Kathleen M Gillooly
Tracy L Taylor
Claudine Pulicicchio
Yifan Zhang
Elizabeth Heimrich
Kim W McIntyre
Qian Ruan
Richard A Westhouse
Charu Chaudhry
Michael A Galella
Andrew J Tebben
Matt Pokross
Rulin Zhao
Daniel Smith
Richard Rampulla
Alban Allentoff
Michael A Wallace
Arvind Mathur
Luisa Salter-Cid
John E Macor
Aberra Fura
James R Burke